Musiani P, Allione A, Modica A, Lollini P L, Giovarelli M, Cavallo F, Belardelli F, Forni G, Modesti A
Istituto di Patologia Umana e Medicina Sociale, Universitá G. D'Annunzio, Chieti, Italy.
Lab Invest. 1996 Jan;74(1):146-57.
Impressive inhibition of tumor growth has been observed after transduction of cytokine genes into tumor cells. Secreted cytokines do not affect the proliferation of a tumor directly but activate a host immune reaction strong enough to overcome its oncogenic capacity. However, the reaction mechanisms activated are difficult to interpret; because these mechanisms have been derived from experiments with different tumors, comparisons are hindered. To compare the reactive mechanisms induced by each cytokine, BALB/c mice were challenged with the parental cells of the syngeneic spontaneous mammary adenocarcinoma TSA, or with TSA cells engineered to release IL2, IL4, IL7, IL10, IFN alpha, IFN gamma, and TNF alpha, and the tumor growth area was studied histologically, ultrastructurally, and immunohistochemically. These observations were integrated with data on the growth and rejection patterns of TSA cells in mice depleted of natural killer (NK) cells, granulocytes, CD4+, or CD8+ lymphocytes. The rejection of TSA-IL2 and TSA-TNF alpha cells was associated with the massive presence of neutrophils, that of TSA-IL4 and TSA-IL7 cells with neutrophils and very small areas of colliquative necrosis, and that of TSA-IFN alpha and TSA-IL10 cells with extensive areas of ischemic-coagulative necrosis and some neutrophils. TSA-IFN gamma cells displayed a delay in growth, but were not rejected. Their growth areas comprised necrotic zones of ischemic necrosis devoid of neutrophils. The selective depletion experiments demonstrated that rejection of engineered TSA cells depends on several leukocyte populations. The weight of each population varied with the secreted cytokine, although neutrophils and CD8+ lymphocytes constantly played the major role. Employment of the same tumor line engineered with the genes of different cytokines showed that each cytokine evokes a distinct reaction and that tumor inhibition results from a complex mechanism in which neutrophils and CD8+ lymphocytes and ischemic necrosis are of primary importance.
将细胞因子基因转导至肿瘤细胞后,已观察到对肿瘤生长有显著抑制作用。分泌的细胞因子并不直接影响肿瘤的增殖,而是激活足以克服其致癌能力的宿主免疫反应。然而,所激活的反应机制难以解释,因为这些机制源自对不同肿瘤的实验,阻碍了比较研究。为了比较每种细胞因子诱导的反应机制,用同基因自发性乳腺腺癌TSA的亲本细胞,或经基因工程改造以释放IL2、IL4、IL7、IL10、IFNα、IFNγ和TNFα的TSA细胞对BALB/c小鼠进行攻击,并从组织学、超微结构和免疫组织化学方面研究肿瘤生长区域。这些观察结果与关于TSA细胞在自然杀伤(NK)细胞、粒细胞、CD4+或CD8+淋巴细胞耗竭的小鼠中的生长和排斥模式的数据相结合。TSA-IL2和TSA-TNFα细胞的排斥与大量中性粒细胞的存在有关,TSA-IL4和TSA-IL7细胞的排斥与中性粒细胞以及非常小面积的液化性坏死有关,TSA-IFNα和TSA-IL10细胞的排斥与大面积的缺血性凝固性坏死和一些中性粒细胞有关。TSA-IFNγ细胞生长延迟,但未被排斥。它们的生长区域包括没有中性粒细胞的缺血性坏死的坏死区。选择性耗竭实验表明,经基因工程改造的TSA细胞的排斥取决于几种白细胞群体。尽管中性粒细胞和CD8+淋巴细胞始终起主要作用,但每个群体的作用大小随分泌的细胞因子而变化。使用用不同细胞因子基因进行基因工程改造的同一肿瘤细胞系表明,每种细胞因子都会引发独特的反应,肿瘤抑制是由一种复杂机制导致的,其中中性粒细胞、CD8+淋巴细胞和缺血性坏死起主要作用。